With regard to treatments and therapies subject to approval for market by Health Canada, from January 1, 2016, to this date: (a) how many pharmaceutical drugs were granted market authorization by Health Canada, broken down by name of drug and date of approval; and (b) of the pharmaceutical drugs listed in (a), how many were for treatments and therapies for rare diseases, known as orphan drugs, broken down by name and date of approval?
In the House of Commons on April 12th, 2021. See this statement in context.